News

The National Institute of Arthritis and Musculoskeletal and Skin Diseases featured an article in its most recent newsletter highlighting the molecular underpinnings of bone loss associated with a condition in which too much parathyroid hormone (PTH) is produced. “The findings, which appeared in the journal Cell Metabolism, suggest that treating patients with existing drugs may help prevent bone loss, sidestepping the need for surgery.” To read the full article, which includes further description of the research findings, visit the NIAMS website.